David Baker - Concepedia

Author

David Baker

Queen Mary University of London ORCID

Also Known As

Baker, D, Carlos E. Balcazar, D BAKER, D Baker, D J Baker, D. Baker, D. J. BAKER, D. J. Baker, D.J. Baker, D.J.M. Baker

409

Publications

21K

Citations

H-Index

242

Concepts

All Affiliations

Queen Mary University of London University College London Barts Health NHS Trust Royal College of Surgeons of England University of Cambridge

About

David Baker is an author at Queen Mary University of London specializing in medicine, neuroimmunology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	45	96	9.1K
2	Health Sciences	11	12	1.3K
3	Natural Sciences	3	3	96
4	Education	2	2	367
5	Engineering	2	2	56

David Baker

187

Publications

14.8K

Citations

H-Index

Page 1

	Year	Citations
Pharmaco-metabonomic phenotyping and personalized drug treatment T. Andrew Clayton, John C. Lindon, Olivier Cloarec, Nature Drug RepositioningPharmacologyPharmacotherapyPharmacogenomicsPharmaco-metabonomic Phenotyping	2006	823
Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism T. Andrew Clayton, David Baker, John C. Lindon, Proceedings of the National Academy of Sciences Host-microbe InteractionsMetabolomic ProfilingDrug FateMetabolic ModelPharmacological Study	2009	756
Cannabinoids control spasticity and tremor in a multiple sclerosis model David Baker, Gareth Pryce, J. Ludovic Croxford, Nature Cannabis UseCannabinoids Control SpasticityPsychiatryHealth SciencesMedicine	2000	529
Immunohistochemical localization of cannabinoid type 1 and vanilloid transient receptor potential vanilloid type 1 receptors in the mouse brain Luigia Cristino, Luciano De Petrocellis, Gareth Pryce, Neuroscience Cannabis UseImmunohistochemical LocalizationNeurophysiologyNeuroanatomyMedicine	2006	484
Identification of epitopes of myelin oligodendrocyte glycoprotein for the induction of experimental allergic encephalomyelitis in SJL and Biozzi AB/H mice. Sandra Amor, N. P. Groome, Christopher Linington, The Journal of Immunology	1994	379
Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells Katarzyna Z. Maresz, Gareth Pryce, Eugene D. Ponomarev, Nature Medicine InflammationCannabinoid Receptor Cb1Cannabis UseAutoimmune DiseaseMedicine	2007	358
In silico patent searching reveals a new cannabinoid receptor David Baker, Gareth Pryce, Wayne I. L. Davies, Trends in Pharmacological Sciences Cannabis UseFunctional SelectivityMedicineNeuropharmacologySilico Patent	2005	345
Regulation of bone mass, bone loss and osteoclast activity by cannabinoid receptors Aymen I. Idris, Rob vanʼt Hof, Iain R. Greig, Nature Medicine Cannabis UseBone LossBone Morphogenic ProteinMedicinePhysiology	2005	345
Cannabinoids inhibit neurodegeneration in models of multiple sclerosis Gareth Pryce, Zubair Ahmed, Deborah J.R. Hankey, Brain ImmunologyImmune RegulationInflammatory AttackSocial SciencesNeuroinflammation	2003	340
Two Years Later: Journals Are Not Yet Enforcing the ARRIVE Guidelines on Reporting Standards for Pre-Clinical Animal Studies David Baker, Katie Lidster, Ana Sottomayor, PLoS Biology Evidence-based MedicineEducationResearch EthicsAnimal ResearchLaboratory Animal Study	2014	309

Page 1